Displaying 11–20 of 184 research results
Sep 24, 2019 Eye On the Cure Research News
Patient benefits from genetic testing for IRDs include confirmation of their clinical diagnosis, identification of the disease inheritance pattern and risk for other family members, and determination of human studies for emerging therapies that may be appropriate for them.
Aug 14, 2019 Eye On the Cure Research News
The treatment focuses on the P23H mutation in the RHO gene, which is the most prevalent variant causing adRP in the US and affects approximately 2,500 people.
Jul 25, 2019 Eye On the Cure Research News
The trial will be the first for a CRISPR/Cas9 therapy administered inside the human body.
Jul 10, 2019 Eye On the Cure Research News
The nonprofit has emerged as a driving force in genetic research and treatment development for inherited retinal diseases.
Jul 9, 2019 Eye On the Cure Research News
A clinical trial for the treatment, designed to preserve cone photoreceptors, is planned in the US and Europe in 2020.
Jun 17, 2019 Science Education
Retinal research paves the way for new treatments for the entire neurological system.
Jun 4, 2019 Eye On the Cure Research News
A federal court ruled that the FDA has regulatory authority over these stem-cell procedures and the power to halt them.
May 21, 2019 Retinal Disease Research Advances
Recent developments in research on Stargardt disease
May 20, 2019 Eye On the Cure Research News
Dr. Zack is a member of the Foundation’s Scientific Advisory Board and chairs its Cellular Molecular Mechanisms of Disease study section.
May 9, 2019 Eye On the Cure Research News
Eye Bonds provide the opportunity to advance, and accelerate development for, more promising treatments into and through clinical trials and out to the people who need them.